First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.42 USD 2.16% Market Closed
Updated: May 1, 2024

Interpace Biosciences Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Interpace Biosciences Inc
Cash from Operating Activities Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Cash from Operating Activities
$2.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Cash from Operating Activities
$2.1B
CAGR 3-Years
1%
CAGR 5-Years
6%
CAGR 10-Years
2%
Quest Diagnostics Inc
NYSE:DGX
Cash from Operating Activities
$1.3B
CAGR 3-Years
-19%
CAGR 5-Years
1%
CAGR 10-Years
6%
CVS Health Corp
NYSE:CVS
Cash from Operating Activities
$13.4B
CAGR 3-Years
-5%
CAGR 5-Years
9%
CAGR 10-Years
9%
Cigna Corp
NYSE:CI
Cash from Operating Activities
$11.8B
CAGR 3-Years
5%
CAGR 5-Years
26%
CAGR 10-Years
32%
Laboratory Corporation of America Holdings
NYSE:LH
Cash from Operating Activities
$1.2B
CAGR 3-Years
-28%
CAGR 5-Years
-2%
CAGR 10-Years
4%

See Also

What is Interpace Biosciences Inc's Cash from Operating Activities?
Cash from Operating Activities
2.4m USD

Based on the financial report for Sep 30, 2023, Interpace Biosciences Inc's Cash from Operating Activities amounts to 2.4m USD.